We are seeing patients in-person and through Video Visits. Learn more about how we’re keeping you safe and please review our updated visitor policy. Please also consider supporting Weill Cornell Medicine’s efforts to support our front-line workers.
Department of Medicine

You are here

Dr. Artis and Team Publish Breakthrough Findings on ILC2s in Immunity

Dr. David Artis

Dr. David Artis, Director of the Jill Roberts Institute for Research in Inflammatory Bowel Disease, and team have published a paper in Immunity that reveals a critical new finding regarding the Tph1 gene and ILC2 (allergy linked immune cells). The study found that ramped-up production of Tph1 helps ILC2s to enter an inflammatory state. This advance may lead to future drugs that could suppress Tph1 in an attempt to alleviate allergic and inflammatory conditions.

Related Links

Weill Cornell Newsroom